For the first time in 20 years, a drug for the treatment of sickle cell disease has been approved in the United Kingdom.
The medicine is expected to reduce the times a patient would need to go to hospital for a crisis by almost half.
But as welcome as the drug may be to millions of sufferers around the world, including here in Nigeria, there are still some barriers.
Arise Correspondent Adefemi Akinsanya reports…
[bc_video video_id=”6275821977001″ account_id=”6116119081001″ player_id=”default” embed=”in-page” padding_top=”56%” autoplay=”” min_width=”0px” playsinline=”” picture_in_picture=”” max_width=”640px” mute=”” width=”100%” height=”100%” ]
Follow us on:
